Clinical Trials

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

How pharma is working to develop efficient and patient-centric trials.

A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.